Related Experiment Video
Updated: Jun 5, 2025
07:35
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
Published on: October 13, 2023
1.6K
SmartGraph API: Programmatic Knowledge Mining in Network-Pharmacology Setting
Gergely Zahoránszky-Kőhalmi1, Brandon Walker1, Nathan Miller1
1National Center for Advancing Translational Sciences (NCATS/NIH), 9800 Medical Center Dr., Rockville, Maryland 20850, United States.
Journal of Chemical Information and Modeling
|December 4, 2024
Summary
The SmartGraph API enhances drug discovery by automating biomedical data integration and hypothesis generation. This network pharmacology tool streamlines complex workflows, improving research efficiency.
Area of Science:
- Computational Biology
- Pharmacology
- Bioinformatics
Background:
- The SmartGraph platform simplifies complex drug discovery workflows within network pharmacology.
- An Application Programming Interface (API) was needed for automated biomedical data integration and hypothesis generation, especially during the COVID-19 pandemic.
Purpose of the Study:
- To address the absence of a comprehensive API for the SmartGraph platform.
- To enable automated biomedical data integration and hypothesis generation in drug discovery.
Main Methods:
- Implemented core SmartGraph functionalities within a new API.
- Adapted the Neo4COVID19 database workflow to leverage the SmartGraph API for automation.
Main Results:
- Successfully transformed a semi-automated workflow into a fully automated one using the SmartGraph API.
- Demonstrated enhanced programmatic integration of network pharmacology knowledge graphs and analytics.
Conclusions:
- The SmartGraph API significantly improves the automation of network pharmacology workflows.
- Facilitates programmatic integration for advanced analytics and predictive modeling in drug discovery.
Related Concept Videos
01:21Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs
1.0K
The fundamental mathematical principles, such as calculus and graphs, play crucial roles in analyzing drug movement and determining pharmacokinetic parameters. Differential calculus examines rates of change and helps to determine the dissolution rate of drugs in biofluids, as well as how drug concentrations change over time. For instance, it can help calculate the rate of elimination of a drug from the body based on its concentration-time profile.
On the other hand, integral calculus focuses on...
On the other hand, integral calculus focuses on...
1.0K
02:26Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
01:26Drug Discovery: Overview
7.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.5K
01:20Pharmacokinetic Models: Overview
582
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
582
01:12Analysis of Population Pharmacokinetic Data
232
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
232
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
56
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
56